The first characterization of TDP-43 was from its inhibitory effects on HIV-1 replication, thus indicating this response as a potential mechanism of combating viral infection (Ou et al., 1995; Rahic et al., 2023). The gene discussed is TARDBP; the disease is viral infectious disease.